Related Experiment Video
Updated: May 4, 2026

08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
12.8K
Isogenic radiation resistant cell lines: development and validation strategies.
Niamh McDermott1, Armelle Meunier, Thomas H Lynch
1Radiation and Urologic Oncology, Applied Radiation Therapy Trinity and Prostate Molecular Oncology Research Group, Discipline of Radiation Therapy, Trinity College Dublin , Ireland.
International Journal of Radiation Biology
|December 20, 2013
Summary
This review analyzes protocols for creating and validating isogenic models of radioresistance. Significant variability exists in current methods, highlighting the need for further model characterization in radiation oncology research.
Area of Science:
- Radiation oncology
- Cancer cell biology
- Molecular response to radiation
Background:
- Isogenic cell line models with varying radiosensitivities are crucial for studying molecular responses to radiation in human cancer.
- Understanding radioresistance mechanisms is vital for improving cancer treatment efficacy.
Purpose of the Study:
- To analyze and compare protocols for the development and validation of isogenic radioresistance models.
- To identify variability in current methodologies for generating and validating these models.
Main Methods:
- Literature review of published studies on isogenic radioresistance models.
- Comparative analysis of protocols for model development and validation.
- Synthesis of findings to identify common themes and discrepancies.
Main Results:
- Substantial variability exists in the strategies employed to generate isogenic radioresistance models.
- Diverse methods are used for the validation of these models, impacting their reliability.
- Lack of standardized protocols complicates the comparison of results across different studies.
Conclusions:
- Current approaches to developing and validating isogenic radioresistance models lack standardization.
- Further comprehensive characterization of these models is essential for advancing radiation oncology research.
- Standardized protocols are needed to ensure the reproducibility and comparability of radioresistance studies.

